Prolonged Cell-cycle Arrest Associated with Altered cdc2 Kinase in Monocrotaline Pyrrole-treated Pulmonary Artery Endothelial Cells
- 1 July 1998
- journal article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 19 (1), 129-142
- https://doi.org/10.1165/ajrcmb.19.1.2895
Abstract
Monocrotaline pyrrole (MCTP), a metabolite of the pyrrolizidine alkaloid monocrotaline, is thought to ini- tiate damage to pulmonary endothelial cells resulting in delayed but progressive pulmonary interstitial edema, vascular wall remodeling, and increasing pulmonary hypertension. MCTP was previously shown to inhibit pulmonary endothelial cell proliferation and cause cell-cycle arrest in vitro . To determine the persistence of arrest and better characterize the cell-cycle stage at which it occurs, bovine pulmonary ar- tery endothelial cells (BPAEC) under differing growth conditions were exposed to low (5 m g/ml) or high (34.5 m g/ml) concentrations of MCTP for varying times. Flow cytometric cell-cycle analysis was coupled with Western blot and biochemical analysis of cdc2 kinase and measurements of cell size. MCTP treat- ment induced a G2 1 M phase arrest in 48-h exposed confluent BPAEC that persisted for at least 28 d and was associated with continued cellular enlargement. A short-duration MCTP exposure of confluent (low and high concentration) and log phase (high concentration) BPAEC caused persistent cell-cycle arrest for 1 wk, whereas a low-concentration exposure in log phase cells resulted in cell-cycle arrest with reversal 96 h after exposure. Western blot examination revealed that by 24 h of MCTP exposure, the phosphorylation state of cdc2 was consistent with the inactive form of the kinase (confirmed by biochemical assay); this al- teration persisted through at least 96 h of exposure. We conclude that MCTP induces a progressive irre- versible endothelial cell dysfunction leading to inactivation of cdc2 kinase and irreversible cell-cycle arrest at the G2 checkpoint. Thomas, H. C., M. W. Lamé, D. Morin, D. W. Wilson, and H. J. Segall. 1998. Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pul- monary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 19:129-142.Keywords
This publication has 26 references indexed in Scilit:
- Comparative Cytotoxicity of Monocrotaline and Its Metabolites in Cultured Pulmonary Artery Endothelial CellsToxicology and Applied Pharmacology, 1997
- Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNAToxicology and Applied Pharmacology, 1996
- Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growthJournal of Cellular Biochemistry, 1993
- Mechanisms and Pathology of Monocrotaline Pulmonary ToxicityCritical Reviews in Toxicology, 1992
- Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrroleToxicology and Applied Pharmacology, 1990
- Review: assessment of cell proliferation in histological material.Journal of Clinical Pathology, 1990
- Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloidsCarcinogenesis: Integrative Cancer Research, 1988
- An ultrastructural study of the pulmonary lesion induced by pyrrole derivatives of the pyrrolizidine alkaloidsThe Journal of Pathology, 1970
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- PYRROLIZIDINE ALKALOIDS AS ALKYLATING AND ANTIMITOTIC AGENTS*Annals of the New York Academy of Sciences, 1969